Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Medication Treatments

Addiction groups target primary care in effort to boost opioid crisis response
02/05/2018
Groups led by the American Academy of Addiction Psychiatry say primary care organizations need substance use disorder training that goes beyond simply certifying more prescribers.
Groups led by the American Academy of Addiction Psychiatry say primary care organizations need substance use disorder training that goes beyond simply certifying more prescribers.
Groups led by the American...
02/05/2018
Addiction Professional
News
Researchers explore medications` possible role in fighting methamphetamine
12/21/2017
Research at the University of Florida is focusing on sigma-1 receptor agonists as a possible drug intervention for individuals in treatment for methamphetamine addiction.
Research at the University of Florida is focusing on sigma-1 receptor agonists as a possible drug intervention for individuals in treatment for methamphetamine addiction.
Research at the University of...
12/21/2017
Addiction Professional
FDA approves once-monthly injectable buprenorphine product
12/01/2017
The FDA has approved a once-monthly injectable form of buprenorphine for the treatment of opioid use disorder, but clinicians are lukewarm on its use.
The FDA has approved a once-monthly injectable form of buprenorphine for the treatment of opioid use disorder, but clinicians are lukewarm on its use.
The FDA has approved a...
12/01/2017
Addiction Professional
News
FDA seeks to encourage development of abuse-deterrent opioid formulations
11/24/2017
The Food and Drug Administration (FDA) this week announced several steps designed to remove barriers to access to abuse-deterrent formulations of opioids.
The Food and Drug Administration (FDA) this week announced several steps designed to remove barriers to access to abuse-deterrent formulations of opioids.
The Food and Drug Administration...
11/24/2017
Addiction Professional
States eye adding gabapentin to controlled substance list
11/22/2017
Reports of increasing misuse of gabapentin, usually in combination with opioids or other drugs, have caught the attention of a number of state regulators.
Reports of increasing misuse of gabapentin, usually in combination with opioids or other drugs, have caught the attention of a number of state regulators.
Reports of increasing misuse of...
11/22/2017
Addiction Professional
Drug studies` results make case for access to all opioid dependence medications
11/16/2017
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.
Recent efficacy and safety...
11/16/2017
Addiction Professional
News
FDA clears electrical device to combat opioid withdrawal
11/15/2017
The Food and Drug Administration (FDA) today announced that an electrical stimulation device attached to the ear can be marketed for the treatment of symptoms of opioid withdrawal.
The Food and Drug Administration (FDA) today announced that an electrical stimulation device attached to the ear can be marketed for the treatment of symptoms of opioid withdrawal.
The Food and Drug Administration...
11/15/2017
Addiction Professional
Hospital boosts opioid patients` rapid access to medication
11/14/2017
The experience of Boston Medical Center bolsters evidence that hospitalized patients with opioid use disorders can be successfully initiated on medication before discharge.
The experience of Boston Medical Center bolsters evidence that hospitalized patients with opioid use disorders can be successfully initiated on medication before discharge.
The experience of Boston Medical...
11/14/2017
Addiction Professional
News
Record-setting amount of prescriptions collected on Take Back Day
11/07/2017
More than 456 tons of unwanted medications were collected for safe disposal during the U.S. Drug Enforcement Administration’s 14th Prescription Drug Take Back Day.
More than 456 tons of unwanted medications were collected for safe disposal during the U.S. Drug Enforcement Administration’s 14th Prescription Drug Take Back Day.
More than 456 tons of unwanted...
11/07/2017
Addiction Professional
News
Injectable buprenorphine moves closer to approval
11/02/2017
It appears likely that the first monthly injectable formulation of buprenorphine to treat opioid dependence will receive federal approval by the end of this month.
It appears likely that the first monthly injectable formulation of buprenorphine to treat opioid dependence will receive federal approval by the end of this month.
It appears likely that the first...
11/02/2017
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement